导致与年龄相关的视网膜退化,并加剧胆膜新血管化
Kenneth J Katschke1, Tom Truong2, Victoria Pham3
1Department of Immunology, Genentech Inc., South San Francisco CA 94080, USA.
Disease models & mechanisms
|August 20, 2025
概括
这项研究表明,眼睛中HTRA1蛋白增加会通过损害光受体导致与年龄相关的黄斑变性 (AMD). 这一发现确定了AMD发病的一个关键因素和潜在的治疗点.
科学领域:
- 眼科 眼科
- 遗传学
- 分子生物学
背景情况:
- 在ARMS2/HTRA1位点的多态性与晚年性黄斑变性 (AMD) 有关.
- 在AMD病理生理学中HTRA1表达的作用尚未完全理解.
- HTRA1突变与大脑微血管缺陷有关.
研究的目的:
- 研究HTRA1蛋白在AMD中的作用.
- 确定HTRA1过度表达是否导致视网膜退化并加剧与AMD相关的病理.
- 在视网膜中识别HTRA1基质.
主要方法:
- 在AMD捐赠者的眼睛中检查HTRA1蛋白水平.
- 在小鼠视网膜色素上皮细胞 (RPE) 中过度表达的催化活性和非活性HTRA1.
- 在小鼠中评估光受体完整性,炎症和功能.
- 使用恒定光暴露 (CLE) 和激光诱导的胆道新血管化 (CNV) 模型.
- 使用蛋白质组学来识别HTRA1基质.
主要成果:
- 在AMD眼睛中,HTRA1蛋白聚集在RPE/光受体病变周围.
- 在小鼠的RPE细胞中,活性HTRA1的过度表达导致了年龄相关的光受体损失,炎症和功能衰退.
- 视网膜退化并未因光毒性压力 (CLE) 而恶化.
- 激活HTRA1过度表达显著加剧了激光诱导的CNV.
- 视觉循环蛋白质视网膜S-arrestin (RBP3) 被确定为一种与疾病相关的HTRA1基质.
结论:
- 通过诱导光受体退化和促进胆道新血管化,HTRA1的积累有助于AMD的发病.
- 由于HTRA1对视网膜的有害作用,其催化活性至关重要.
- RBP3是HTRA1在视网膜中的新型疾病相关基质,表明HTRA1引起的视网膜损伤的机制.
相关概念视频
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:16Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...